Douglas Carr's most recent trade in Century Therapeutics Inc was a trade of 1,654 Common Stock done at an average price of $2.2 . Disclosure was reported to the exchange on June 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 2.23 per share. | 12 Jun 2026 | 1,654 | 505,094 | - | 2.2 | 3,692 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 2.11 per share. | 08 Jun 2026 | 249 | 506,748 | - | 2.1 | 526 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 2.34 per share. | 04 May 2026 | 264 | 506,997 | - | 2.3 | 618 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 2.55 per share. | 12 Mar 2026 | 7,043 | 507,261 | - | 2.5 | 17,953 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 2.53 per share. | 09 Mar 2026 | 247 | 514,304 | - | 2.5 | 626 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 1.82 per share. | 03 Feb 2026 | 323 | 514,551 | - | 1.8 | 589 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 225,000 | 225,000 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 110,000 | 514,874 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.53 per share. | 08 Dec 2025 | 257 | 404,874 | - | 0.5 | 137 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 03 Nov 2025 | 292 | 405,131 | - | 0.6 | 171 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.50 per share. | 08 Sep 2025 | 263 | 405,423 | - | 0.5 | 132 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.53 per share. | 04 Aug 2025 | 296 | 405,686 | - | 0.5 | 158 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 09 Jun 2025 | 4,904 | 405,982 | - | 0.6 | 3,050 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.55 per share. | 05 May 2025 | 295 | 410,886 | - | 0.5 | 162 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 95,625 | 95,625 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 95,625 | 411,181 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 10 Mar 2025 | 1,240 | 315,556 | - | 0.6 | 763 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 03 Feb 2025 | 351 | 316,796 | - | 0.8 | 274 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 01 Nov 2024 | 16,611 | 317,430 | - | 1.3 | 20,930 | Common Stock | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 01 Nov 2024 | 283 | 317,147 | - | 1.2 | 347 | Common Stock | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 05 Aug 2024 | 289 | 334,041 | - | 1.8 | 528 | Common Stock | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 07 Jun 2024 | 17,007 | 334,330 | - | 0 | Common Stock | ||
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 03 May 2024 | 257 | 317,323 | - | 3.1 | 798 | Common Stock | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 07 Mar 2024 | 81,000 | 81,000 | - | - | Stock Option (right to buy) | ||
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 07 Mar 2024 | 14,000 | 317,580 | - | 0 | Common Stock | ||
| Century Therapeutics Inc | Carr Douglas | SVP Finance & Operations | 05 Feb 2024 | 643 | 304,137 | - | 3.8 | 2,470 | Common Stock | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 05 Feb 2024 | 557 | 303,580 | - | 4.5 | 2,499 | Common Stock | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 15 May 2023 | 120,846 | 321,391 | - | 0 | Common Stock | ||
| Century Therapeutics Inc | Douglas Carr | VP Finance & Operations | 02 Feb 2023 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | ||
| Century Therapeutics Inc | Douglas Carr | VP Finance & Operations | 02 Feb 2023 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | ||
| Century Therapeutics Inc | Douglas Carr | VP Finance & Operations | 02 Feb 2023 | 7,500 | 200,545 | - | 0 | Common Stock | ||
| Century Therapeutics Inc | Douglas Carr | VP Finance & Operations | 02 Feb 2023 | 7,500 | 193,045 | - | 0 | Common Stock | ||
| Century Therapeutics Inc | Douglas Carr | VP of Finance and Operations | 25 Jan 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) |